By: Max Bayer, Alex Hoffman
1 day ago
Copy Chief and News Editor Biotech Correspondent Uli Stilz has been trotting the globe this year to talk about the future of biotech and bridge an increasingly international industry. He was in …
Endpoints News is a specialized media outlet dedicated to delivering comprehensive coverage of the biotechnology and pharmaceutical industries. The publication focuses on the intersection of science, business, and finance, providing in-depth reporting on the innovations, people, and capital flows that shape these dynamic sectors. Its editorial scope spans medicine and healthcare broadly—including pharmaceuticals, healthtech, alternative medicine, wellness trends, and developments within healthcare systems.
The primary audience for Endpoints News includes industry professionals such as biotech executives, pharmaceutical leaders, investors, researchers, analysts, policy makers in healthcare regulation or innovation spaces—essentially anyone seeking authoritative updates on the business side of life sciences. It also appeals to those interested in understanding how scientific advancements translate into market realities.
Endpoints News employs a mix of data-driven analysis and expert opinion pieces alongside informative reviews and promotional content. This multifaceted approach ensures readers receive both factual reporting on emerging trends or deals as well as thoughtful commentary from industry insiders.
Content is distributed primarily through its online digital platform but may also be available in digital print formats for subscribers or special reports. This ensures timely access to breaking news and deep dives relevant to stakeholders across the global biotech and pharma landscape.
